From July 1, 2021 to December 31, 2021, the company has repurchased 17,084,000 shares, representing 4.33% for HKD 37.25 million. With this, the company has completed the repurchase of 19,858,000 shares, representing 5.03% for HKD 43.9 million under the buyback announced on June 2, 2021.
Lansen Pharmaceutical Holdings Limited
Equities
503
KYG5380M1033
Pharmaceuticals
1st Jan change | Capi. | |
---|---|---|
+32.27% | 588B | |
-3.28% | 364B | |
+19.24% | 326B | |
+4.88% | 285B | |
+15.51% | 239B | |
+10.35% | 210B | |
-7.16% | 200B | |
+8.67% | 167B | |
-0.49% | 161B |